Activity Reports
Public Comment
National and international regenerative medicine trends
About FIRM
Contact Us
FIRM mark certification

FIRM mark certification

FIRM mark certification

Member Introduction

EN
JP

Sitemap

Activity Report List
Supporting Industries Committee
Cell and Gene Therapy Products(CGTP’s) Committee
Specific Processed Cells Committee
Standardization Committee
Public Affairs Committee
International Affairs Committee
Education Implementation Committee
Venture Establishment / Promotion Committee
Committee to Standardize Foundation for Cell Characterization and Cell Production
ISO/TC 276 Japan Mirror Committee
Committee for Non-Clinical Safety Evaluation of Pluripotent Stem Cell-derived Product
Event report

About FIRM
A message from the Chairperson
Company Info
Organization Chart
Access
Overview FIRM History
FIRM VISION 2025
Member Introduction
FIRM Brochure
FIRM Startup / Private Company Map

FIRM mark certification

Member
Introduction

Member
only

English ｜ FIRM Startup / Private Company Map ｜ OthersClinical Trial (Phase II)

Others
Clinical Trial (Phase II)

Release date: 2023/10/4

■ PDF Download

Clinical development pipelines　/　Cyfuse Biomedical K.K.
Antigen specific iTs (induced T cells with suppressing function) cell therapy　/　JUNTEN BIO Co., Ltd.

Sitemap

(c) Forum for Innovative Regenerative Medicine